In the context of COVID-19 vaccinations, certain highly heterogeneous and generally prolonged symptoms that have occurred in vaccinated individuals with a temporal relationship to vaccination are also referred to as “post-vaccine syndrome”. Information from Swissmedic on individual safety aspects Post-vaccine syndrome However, the Agency will continue to monitor COVID-19 vaccines closely and new information on risks and safety signals will be communicated via the usual channels (website, DHPCs). The vaccines authorised in Switzerland reliably reduce the risk of contracting severe COVID-19.įor some time now, Swissmedic has been receiving far fewer reports of suspected adverse reactions than when vaccination first started and will therefore provisionally cease publishing regular updates on reported adverse reactions to COVID-19 vaccines in their current form. Thanks to the widespread use of COVID-19 vaccines, it is possible to continually gather up-to-date and comprehensive data on the risk-benefit ratio and include information on as-yet unknown rare side effects in the medicinal product information. The reports of suspected adverse drug reactions (ADR) to COVID-19 vaccinations are evaluated in collaboration with the regional pharmacovigilance centres and in particular with the Ticino reference centre (EOC cantonal hospital authority).Īccording to the World Health Organization (WHO), over 13 billion doses of coronavirus (SARS-CoV-2) vaccine had been administered worldwide as at 14 February 2023.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |